Ligand ID: RO7 Drugbank ID: DB08915(Aleglitazar) Indication:Investigated for use in patients with type II diabetes to reduce their risks of cardiovascular mortality and morbidity. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 12 | GLY B 124SER B 144HIS B 163TYR B 161VAL B 13 | 1.49A | 22.19 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 1uk3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 124SER A 144HIS A 163TYR A 161VAL A 13 | 1.35A | 22.57 | None | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | VAL B1114CYH B1128ILE B1106ILE B1200VAL B1204 | 1.78A | 22.98 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 4 / 7 | LEU D 19GLN E 93LEU A 60VAL A 16 | 1.08A | 18.11 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 2amd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | SER A 147HIS A 163LEU A 27VAL A 20HIS A 164 | 1.41A | 22.29 | None9IN A1001 (-3.8A)9IN A1001 ( 4.5A)NoneNone | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 2beq | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 7 | LEU E1168GLN C 915LEU D1179LEU B 920LYS A 914 | 1.71A | 12.35 | NoneNoneACE B 913 ( 4.8A)NoneNone | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 2dd8 | IGG HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | VAL S 496TYR S 436ILE S 405ILE H 56TYR S 484 | 1.65A | 20.00 | None | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 12 | CYH T 74CYH T 73SER T 72ILE T 55ILE T 99 | 1.74A | 20.38 | ZN T 998 (-2.2A)NoneNoneNoneNone | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 2gt8 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 120CYH A 117SER A 144TYR A 126VAL A 13 | 1.29A | 22.50 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 2op9 | REPLICASEPOLYPROTEIN 1AB(PP1AB, ORF1AB)3C-LIKE PROTEINASE(3CL-PRO, 3CLP) (SARSr-CoV) | 5 / 12 | GLY A 124SER A 144HIS A 163TYR A 161VAL A 13 | 1.52A | 22.51 | NoneWR1 A 601 (-3.5A)NoneNoneNone | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | VAL D 291SER B 241MET D 271ILE D 269ILE B 235 | 1.52A | 23.08 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 4 / 7 | LEU A 248VAL A 320LEU A 297LEU A 75 | 0.97A | 23.08 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 2pwx | 3C-LIKE PROTEINASE (SARS-COVBJ01) | 5 / 7 | LEU A 86GLN A 19VAL A 148LEU A 32LYS A 97 | 1.72A | 22.74 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | GLY A 124SER A 144HIS A 163TYR A 161VAL A 13 | 1.47A | 22.57 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 2qc2 | 3C-LIKE PROTEINASE (-) | 5 / 12 | GLY B 124SER B 144HIS B 163TYR B 161VAL B 13 | 1.40A | 22.50 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 2qcy | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 7 | LEU A 86GLN A 19VAL A 148LEU A 32LYS A 97 | 1.61A | 22.98 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 2qiq | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | GLY A 124SER A 144HIS A 163TYR A 161VAL A 13 | 1.51A | 22.65 | NoneCYV A 302 ( 4.2A)CYV A 302 (-3.9A)NoneNone | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | VAL B 20CYH B 145SER B 144HIS B 172TYR B 126 | 1.69A | 23.71 | NoneXP1 B1304 (-1.8A)NoneNoneNone | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 124SER A 144HIS A 163TYR A 161VAL A 13 | 1.46A | 22.29 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 2xyq | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 7 | LEU A 161VAL A 67LEU A 59LEU A 180 | 1.10A | 20.79 | NoneNone NA A1295 (-4.3A)None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 2xyr | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 7 | LEU A 161VAL A 67LEU A 59LEU A 180 | 1.06A | 20.79 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 3atw | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 124SER A 144HIS A 163TYR A 161VAL A 13 | 1.44A | 22.57 | NoneHSV C 5 (-3.6A)HSV C 5 (-4.1A)NoneNone | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 7 | LEU B 236GLN B 526VAL B 581LEU B 450 | 1.02A | 18.53 | None | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | SER B 170TYR B 497ILE B 151HIS B 493VAL B 491 | 1.72A | 18.53 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 3e91 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 124SER B 144HIS B 163TYR B 161VAL B 13 | 1.47A | 22.58 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 124SER A 144HIS A 163TYR A 161VAL A 13 | 1.52A | 22.58 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 124SER B 144HIS B 163TYR B 161VAL B 13 | 1.51A | 22.57 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 3m3t | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 7 | LEU A 86GLN A 19VAL A 148LEU A 32LYS A 97 | 1.63A | 22.98 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 124SER A 144HIS A 163TYR A 161VAL A 13 | 1.45A | 22.51 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 3r24 | 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 7 | LEU A 161VAL A 67LEU A 59LEU A 180 | 1.08A | 20.68 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 3scj | ACE2 (Homosapiens) | 4 / 7 | LEU B 236GLN B 526VAL B 581LEU B 450 | 1.04A | 18.23 | None | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | SER A 170TYR A 497ILE A 151HIS A 493VAL A 491 | 1.64A | 18.47 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 7 | LEU B 236GLN B 526VAL B 581LEU B 450 | 1.01A | 18.47 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 124SER B 144HIS B 163TYR B 161VAL B 13 | 1.46A | 22.94 | None | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 5b6o | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | VAL A 114CYH A 128ILE A 106ILE A 200VAL A 204 | 1.79A | 24.10 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 5b6o | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 124SER B 144HIS B 163TYR B 161VAL B 13 | 1.50A | 21.58 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 5f22 | NSP8NSP7 (SARSr-CoV) | 5 / 7 | LEU B 133GLN A 36LEU A 18VAL A 58LEU A 65 | 1.67A | 19.77 | None | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 5tl7 | REPLICASEPOLYPROTEIN 1ABUBIQUITIN-LIKEPROTEIN ISG15 (Musmusculus;SARSr-CoV) | 5 / 12 | VAL C 115TYR D 265MET D 209VAL D 166TYR D 274 | 1.76A | 17.26 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 5x5f | S PROTEIN (MERS-CoV) | 5 / 12 | GLY B 572LEU B 415VAL B 420LEU B 441TYR B 438 | 1.32A | 11.48 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 7 | LEU C 959GLN C 984LEU C 745LEU C 735 | 1.01A | 12.68 | LEU C 959 ( 0.6A)GLN C 984 ( 0.6A)LEU C 745 ( 0.5A)LEU C 735 ( 0.6A) | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 7 | LEU B 959GLN B 984LEU B 745LEU B 735 | 1.08A | 12.68 | None | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | CYH A 19CYH A 133ILE A 152MET A 151VAL A 102 | 1.56A | 12.68 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 7 | LEU C 615GLN C 630VAL C 596LEU A 831 | 1.12A | 12.92 | NoneNAG C1311 (-3.1A)NoneNAG C1311 (-4.8A) | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6cs2 | ACE2 (Homosapiens) | 5 / 12 | SER D 170TYR D 497ILE D 151HIS D 493VAL D 491 | 1.79A | 18.23 | None | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6m17 | ACE2 (Homosapiens) | 5 / 12 | SER D 170TYR D 497ILE D 151HIS D 493VAL D 491 | 1.56A | 16.56 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6m17 | ACE2 (Homosapiens) | 4 / 7 | LEU B 236GLN B 526VAL B 581LEU B 450 | 1.11A | 16.56 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6m18 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 7 | LEU A 424LEU A 244LYS A 409LEU A 389 | 1.09A | 16.67 | None | ||
![]() | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6m18 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | VAL C 505SER C 291TYR C 292ILE C 15VAL C 441 | 1.64A | 16.67 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6vw1 | ACE2 (Homosapiens) | 4 / 7 | LEU A 236GLN A 526VAL A 581LEU A 450 | 1.01A | 18.29 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | GLY L 64TYR L 36ILE L 75LEU L 33TYR L 91 | 1.65A | 19.85 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | GLN L 38LEU L 46VAL L 58LEU L 73 | 1.73A | 18.77 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | GLN L 147LEU L 181VAL L 133LEU L 154 | 1.46A | 18.77 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 4 / 7 | LEU H 82GLN H 6VAL H 67LEU H 4 | 1.71A | 19.49 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | GLN L 38LEU L 73VAL L 58LEU H 45 | 1.68A | 18.77 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | GLN L 38LEU L 73LEU L 11LEU H 45 | 1.71A | 18.77 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | GLN L 147LEU L 175VAL L 115LEU L 201 | 1.51A | 18.77 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | LEU L 78GLN L 38LEU L 11LEU H 45 | 1.49A | 18.77 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | LEU L 175GLN L 147LEU L 181VAL L 133 | 1.57A | 18.77 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | GLN L 38LEU L 47LEU L 78LEU H 45 | 1.79A | 18.77 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | LEU L 73GLN L 42VAL L 104LEU L 78 | 1.59A | 18.77 | NoneSO4 L 302 (-4.2A)NoneNone | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | GLY C 70TYR C 42ILE C 81LEU C 39TYR C 97 | 1.74A | 20.28 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | GLY L 70TYR L 42ILE L 81LEU L 39TYR L 97 | 1.73A | 20.28 | None | ||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6yla | LIGHT CHAIN (Homosapiens) | 4 / 7 | GLN C 153LEU C 181VAL C 121LEU C 207 | 1.43A | None | |||
![]() | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) | 6ym0 | LIGHT CHAIN (Homosapiens) | 4 / 7 | GLN L 153LEU L 187VAL L 139LEU L 160 | 1.36A | None | |||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 6ym0 | LIGHT CHAIN (Homosapiens) | 5 / 12 | GLY L 70TYR L 42ILE L 81LEU L 39TYR L 97 | 1.75A | 20.28 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | GLY L 70TYR L 42ILE L 81LEU L 39TYR L 97 | 1.72A | 20.28 | None | ||
![]() | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | GLY C 70TYR C 42ILE C 81LEU C 39TYR C 97 | 1.73A | 20.28 | None |